214 related articles for article (PubMed ID: 28011331)
21. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
[TBL] [Abstract][Full Text] [Related]
22. Multidrug-resistant tuberculosis in pregnancy: case report and review of the literature.
Lessnau KD; Qarah S
Chest; 2003 Mar; 123(3):953-6. PubMed ID: 12628902
[TBL] [Abstract][Full Text] [Related]
23. Radiometric vs. agar proportion methods for assessing ethionamide resistance and its clinical effects in multidrug-resistant tuberculosis.
Cimen NO; Arslan Z; Saygi A; Ocak K; Babacan F; Kurutepe M
Int J Tuberc Lung Dis; 2009 Jul; 13(7):907-13. PubMed ID: 19555543
[TBL] [Abstract][Full Text] [Related]
24. Quinolones and multidrug-resistant tuberculosis.
Maranetra KN
Chemotherapy; 1999; 45 Suppl 2():12-8. PubMed ID: 10449893
[TBL] [Abstract][Full Text] [Related]
25. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
Li L; Zheng SH; Chu NH; Xie YG; Yang YZ; Li Q; Wang XM; Yan XL; Tan WG; Miao ZP; Duanmu HJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3387-91. PubMed ID: 19159566
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
27. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
28. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases].
Shigetoh E; Murakami I; Yokosaki Y; Kurimoto N
Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128
[TBL] [Abstract][Full Text] [Related]
29. Drug resistance to the first line of antitubercular regimen (a preliminary report).
Varaiya A; Gogate A
Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Singla R; Gupta S; Gupta R; Arora VK
Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
[TBL] [Abstract][Full Text] [Related]
31. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
32. Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
Centers for Disease Control and Prevention
MMWR Recomm Rep; 2013 Oct; 62(RR-09):1-12. PubMed ID: 24157696
[TBL] [Abstract][Full Text] [Related]
33. Pattern of secondary acquired drug resistance to antituberculosis drug in Mumbai, India--1991-1995.
Chowgule RV; Deodhar L
Indian J Chest Dis Allied Sci; 1998; 40(1):23-31. PubMed ID: 9727280
[TBL] [Abstract][Full Text] [Related]
34. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004.
Bai GH; Park YK; Choi YW; Bai JI; Kim HJ; Chang CL; Lee JK; Kim SJ
Int J Tuberc Lung Dis; 2007 May; 11(5):571-6. PubMed ID: 17439684
[TBL] [Abstract][Full Text] [Related]
35. Immune disturbances in female genital tuberculosis and latent genital tuberculosis.
Sharma JB; Sharma S; Sharma E; Dharmendra S; Singh S
Am J Reprod Immunol; 2023 Feb; 89(2):e13632. PubMed ID: 36494901
[TBL] [Abstract][Full Text] [Related]
36. Hysteroscopic observations in 348 consecutive cases of female genital tuberculosis: A prospective study.
Sharma JB; Singh UB; Kriplani A; Kumar S; Roy KK; Kumari A; Dharmendra S
Indian J Tuberc; 2022 Jan; 69(1):48-57. PubMed ID: 35074151
[TBL] [Abstract][Full Text] [Related]
37. Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.
Nagaraja C; Shashibhushan BL; Asif M; Manjunath PH; Sagar C
Indian J Chest Dis Allied Sci; 2012; 54(1):23-6. PubMed ID: 22779119
[TBL] [Abstract][Full Text] [Related]
38. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of female genital tuberculosis, its risk factors and associated clinical features among the women of Andaman Islands, India: a community-based study.
Parvez R; Sugunan AP; Vijayachari P; Burma SP; Mandal A; Saha MK; Shah WA
Public Health; 2017 Jul; 148():56-62. PubMed ID: 28404534
[TBL] [Abstract][Full Text] [Related]
40. Drug resistance to tuberculosis in a tertiary care setting in Karachi.
Akhtar S; Haidri FR; Memon AM
J Pak Med Assoc; 2007 Jun; 57(6):282-4. PubMed ID: 17629227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
